Capital Advisors, Ltd. LLC Allakos Inc. Transaction History

Capital Advisors, Ltd. LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$1.0 - $1.45 $301 - $436	301 New	301 $0
Q2 2023 Jul 26, 2023	SELL	$3.6 - $5.25 $14 - $21	-4 Reduced 7.14%	52 $0
Q1 2023 May 03, 2023	SELL	$4.3 - $8.27 $94 - $181	-22 Reduced 28.21%	56 $0
Q4 2022 Feb 07, 2023	BUY	$5.66 - $8.42 $113 - $168	20 Added 34.48%	78 $1,000
Q2 2022 Aug 05, 2022	SELL	$2.6 - $6.14 $39 - $92	-15 Reduced 20.55%	58 $0
Q1 2022 May 09, 2022	BUY	$5.08 - $9.81 $370 - $716	73 New	73 $0

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $74.6M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.